KILITCH — Kilitch Drugs (India) Balance Sheet
0.000.00%
- IN₹5.75bn
- IN₹5.48bn
- IN₹1.54bn
- 73
- 24
- 91
- 71
Annual balance sheet for Kilitch Drugs (India), fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 306 | 488 | 572 | 591 | 690 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 187 | 260 | 430 | 566 | 658 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 558 | 804 | 1,141 | 1,264 | 1,460 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 383 | 734 | 464 | 474 | 481 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 1,428 | 2,032 | 2,098 | 2,195 | 2,401 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 220 | 733 | 693 | 689 | 642 |
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 246 | 760 | 708 | 679 | 638 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 1,183 | 1,271 | 1,391 | 1,516 | 1,763 |
Total Liabilities & Shareholders' Equity | 1,428 | 2,032 | 2,098 | 2,195 | 2,401 |
Total Common Shares Outstanding |